BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2443909)

  • 21. High performance liquid chromatographic strategy for the analysis of exopolysaccharides extracted from pathogenic bacteria.
    Radin L; Sivori S; Eftimiadi C; Lucarelli C
    Biomed Chromatogr; 1992; 6(3):115-9. PubMed ID: 1525483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrolysis of pullulan by entrapped pullulanase in Ca/alginate beads.
    Gasmi SN; Rihouey C; Picton L; Le Cerf D
    Biopolymers; 2014 Sep; 101(9):938-44. PubMed ID: 24633755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of the Limulus amebocyte lysate assay for the analysis of glucan in indoor environments.
    Foto M; Plett J; Berghout J; Miller JD
    Anal Bioanal Chem; 2004 May; 379(1):156-62. PubMed ID: 15042272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structure of a dextran produced by Leuconostoc mesenteroides NRRL B-1397: the linkages and length of the branches.
    Miyaji H; Misaki A
    Carbohydr Res; 1973 Dec; 31(2):277-87. PubMed ID: 4361479
    [No Abstract]   [Full Text] [Related]  

  • 25. Gel permeation chromatography of dextrans in parenteral solutions: calibration procedure development and method validation.
    Karmarkar S; Garber R; Kluza J; Koberda M
    J Pharm Biomed Anal; 2006 Jun; 41(4):1260-7. PubMed ID: 16650708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insight into the distribution of molecular weights and higher-order structure of hyaluronans and some beta-(1 --> 3)-glucans by size exclusion chromatography.
    Soltés L; Mislovicová D; Sébille B
    Biomed Chromatogr; 1996; 10(2):53-9. PubMed ID: 8924726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calibration of gel-chromatographic columns for examination of dextrans for clinical use].
    Araco A; Frontali C
    Ann Ist Super Sanita; 1976; 12(4):289-94. PubMed ID: 1030603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of bacterial exopolysaccharides.
    Kennedy AF; Sutherland IW
    Biotechnol Appl Biochem; 1987 Feb; 9(1):12-9. PubMed ID: 3032214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An experimental study on the effect of plasma expanders on blood coagulability.
    Narita T; Matsumoto I; Kumazawa T; Ikezono E
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on hydroxyethyl starch. Part I: Molecular characterization by size exclusion chromatography coupled with low-angle laser light scattering.
    Lederer K; Huber C; Dunky M; Fink JK; Ferber HP; Nitsch E
    Arzneimittelforschung; 1985; 35(3):610-4. PubMed ID: 2581590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Size-exclusion capillary electrochromatographic separation of polysaccharides using polymeric stationary phases.
    Mistry K; Krull I; Grinberg N
    Electrophoresis; 2003 Jun; 24(11):1753-63. PubMed ID: 12783452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on hydroxyethyl starch as a plasma expander. II. Influences of molecular weight of hydroxyethyl starch on its physicochemical and biological properties.
    Tamada T; Okada K; Ishida R; Kamishita K; Irikura T
    Chem Pharm Bull (Tokyo); 1971 Feb; 19(2):286-91. PubMed ID: 5549054
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)].
    Köhler H; Zschiedrich H; Clasen R; Linfante A; Gamm H
    Anaesthesist; 1982 Feb; 31(2):61-7. PubMed ID: 6177264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macromolecular prodrugs. V. Simultaneous determination of high-molecular-weight dextran metronidazole monosuccinate ester prodrugs and the hydrolysis products metronidazole and the corresponding monosuccinate ester on nucleosil diol.
    Larsen C; Johansen M
    J Chromatogr; 1987 Feb; 389(1):227-35. PubMed ID: 2437137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for hydroxyethyl starch (HES) doping in sport.
    Scalco FB; Simoni RE; de Oliveira ML; Gomes LN; Neto FR
    J Sci Med Sport; 2010 Jan; 13(1):13-5. PubMed ID: 18768354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
    Ehrly AM; Seebens H; Saeger-Lorenz K
    Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of kidney function on the elimination and action of colloidal plasma substitutes].
    Köhler H
    Fortschr Med; 1979 Oct; 97(40):1809-13. PubMed ID: 94298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synthetic plasma substitutes].
    Giacomello M; Casiglia E; Gava R; Sforza G
    G Clin Med; 1989 Oct; 70(10):615-8. PubMed ID: 2480925
    [No Abstract]   [Full Text] [Related]  

  • 39. Fractionation of dextran and Ficoll by chromatography on Sephadex G-200.
    Laurent TC; Granath KA
    Biochim Biophys Acta; 1967 Mar; 136(2):191-8. PubMed ID: 6049492
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Infusionsther Klin Ernahr; 1979 Jun; 6(3):151-5. PubMed ID: 88413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.